Synnovation launches with $102m to advance therapy pipeline

Synnovation Therapeutics has launched with a $102m Series A financing to progress the development its pipeline of targeted therapies.

Related Posts

What health policies could hitch a ride on a spending b...

Nov 15, 2023

Risk adjusted net present value: What is the current va...

Dec 15, 2024

Pfizer’s Ngenla finally secures FDA approval following ...

Jun 29, 2023